danazol has been researched along with 2019 Novel Coronavirus Disease in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 3 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Apte, SH; Bancroft, S; Chambers, DC; Corte, TJ; Dickinson, JL; Enever, D; Glaspole, I; Goh, NS; Grainge, C; Hopkins, P; Jaffe, A; Lutzky, V; Mackintosh, JA; Pickett, HA; Pietsch, M; Reynolds, PN; Selvadurai, H; Tan, M; Wrobel, J; Yerkovich, ST | 1 |
| Madan, S; Mehra, MR | 1 |
| Boğatekin, G; Bulut, G; Demir, S; Gelincik, A; Kuman Tunçel, O; Mete Gökmen, N; Mungan, D; Tunakan Dalgıç, C | 1 |
1 trial(s) available for danazol and 2019 Novel Coronavirus Disease
| Article | Year |
|---|---|
TELO-SCOPE study: a randomised, double-blind, placebo-controlled, phase 2 trial of danazol for short telomere related pulmonary fibrosis.
Topics: Australia; Child; COVID-19; Danazol; Humans; Pulmonary Fibrosis; Telomere; Treatment Outcome | 2021 |
2 other study(ies) available for danazol and 2019 Novel Coronavirus Disease
| Article | Year |
|---|---|
Rhabdomyolysis with the combined use of danazol and rosuvastatin in left ventricular assist devices.
Topics: Adult; Comorbidity; COVID-19; Danazol; Drug Therapy, Combination; Estrogen Antagonists; Heart Failure; Heart-Assist Devices; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Male; Middle Aged; Rhabdomyolysis; Rosuvastatin Calcium; Treatment Outcome | 2020 |
Psychiatric and Clinical Characteristics of Hereditary Angioedema Patients Who Experienced Attacks During COVID-19.
Topics: Adult; Angioedemas, Hereditary; Anxiety; COVID-19; Danazol; Female; Humans; Male; Middle Aged; SARS-CoV-2; Tranexamic Acid; Turkey | 2021 |